Shuttle Pharmaceuticals Holdings, Inc.SHPHEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Shuttle Pharmaceuticals Holdings, Inc. is a US-based clinical-stage biopharmaceutical company focused on developing novel radioprotective therapies and cancer supportive care products. It primarily operates in the oncology care segment, targeting unmet medical needs to reduce side effects of radiation therapy for cancer patients, and collaborates with clinical research partners to advance its late-stage product pipeline.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| NOS. OF ABOVE PERSONS | 3.80% | 597.1K | ▼ -5.34pp | 2023-10-18 |